|
Partnerships with MVP are win-win:
- MVP's scientific diligence is extremely thorough as its experienced staff has a broad understanding of the field and access to many experts in the academic and clinical communities.
- MVP also provides benefit to co-investors via its deep understanding of and access to future market populations.
- Through MDA's valuable clinical infrastructure (research networks and registries), MVP offers added value to companies developing therapies in our diseases.
- Although MVP has the capability of conducting professional diligence in the areas of finance, management and intellectual property, it welcomes the opportunity to partner with other funders who have complementary skill sets.
- MVP's return on investment strategy is typically nondilutive.
For more information, contact Jane Larkindale at (520) 615-6702 and jlarkindale@mdavp.org. |
